Benedictor Alexander Nguchu1, Jing Zhao 2,3, Yanming Wang1, Jean de Dieu Uwisengeyimana1, Xiaoxiao Wang1, Bensheng Qiu1, and Hongjun Li2,3
1Hefei National Lab for Physical Sciences at the Microscale and the Centers for Biomedical Engineering, University of Science and Technology of China, Hefei, China, 2Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing, China, 3School of Biological Science and Medical Engineering, Beihang University, Beijing, China
Synopsis
The brain
activity underlying cognitive processing can be affected by HIV. We examine the
ALPS index, a measure reflecting glymphatic system activity, along the perivascular space and its relationship with cognitive performance in
middle-aged HIV infected patients successfully adhering to antiretroviral
therapy. We found that the ALPS index was increased significantly in middle-aged
HIV-infected patients receiving cART and was correlated with attention and
working memory. The duration on cART was also associated with some cognitive measures.
These findings suggest that ALPS index might provide an impetus for
understanding cognitively relevant diffusivity changes following HIV or long-term use of cART.
Introduction
HIV infection
is associated with neuroinflammation that plays a key role in the pathogenesis
of several neurological disorders such as cognitive impairment1. These inflammations can
be reduced through combination antiretroviral therapy (cART)2. We hypothesize that one
possible mechanism through which inflammation is reduced might be by glymphatic
system3 4, possibly allowing
diffusion of HIV inflammation fluids, neurotoxins, amyloid- đœ, tau, and other brain metabolites5, thereby improves
cognitive functions. The system depends on fluid transportation through the perivascular
space and interstitial space6. Recently, studies7 have shown that glymphatic
system evaluation can be achieved by Diffusion Tensor Imaging (DTI), allowing
evaluation of water diffusivity along the x-direction of the
periventricular white matter. Here, using DTI analysis along perivascular
space (ALPS) index, we assessed the glymphatic system activity in
middle-aged HIV-infected patients successfully adhering to cART, in association
with cognitive performance and cART. Methods
Twenty seven
middle-aged HIV patients on cART (tenofovir (TDF) + lamivudine (3TC) +
efavirenz (EFV) (mean± SD age = 40.37 ± 4.74 years, range = 36 – 55 years) and
28 age-matched healthy controls (41.35± 4.84 years, range = 36 – 55 years) were
recruited at Beijing YouAn Hospital from March 2016 to November 2016 for imaging
and clinical neuropsychological assessments (Table 1). Siemens 3T MRI Scanner (TRIO TIM, Siemens
Medical System, Erlangen, Germany) equipped with a 32-channel head coil was
used to acquire images. Imaging protocols include a T1-weighted anatomical image
(TR/TE=1900 ms/2.52 ms, inversion time = 900 ms, flip angle = 9°, field of view (FVO)=250
× 250 mm2, matrix size = 246×256, slice thickness = 1 mm, and voxel
size =1 ×0.977 ×0.977 mm3) and a Diffusion-weighted imaging(DWI) sequence (60 diffusion-encoded (b=1000
s/mm2 ), 3 reference (b=0 s/mm2 ), TR=3300ms, TE=90 ms, flip angle =
90°, slice thickness= 4.2 mm, voxel size=2×2×4.2 mm3 ). DWI data
were preprocessed using FSL (https://fsl.fmrib.ox.ac.uk/) and diffusivity
maps were computed5. High-resolution
T1w images were coregistered to the JHU ICBM template, and the same
transformations were applied to the corresponding diffusivity maps. As it
matches the direction of the deep white matter vessels, the water diffusivity
along the x-axis is partly considered to reflect glymphatic system7. Using projection
and association fibers (Figure 1) in the periventricular white matter from JHU ICBM-DTI-81
white matter atlas, passing along the wall of the lateral ventricles
perpendicular to the x-axis, we computed the diffusivity along the x- and y-directions
for the projection fibers (Dxpro, Dypro), and along the x- and z-directions for
association fibers (Dxasc, Dzasc). The ALPS index5 7 was then
estimated as follow: $$ALPS index=mean (Dxpro, Dxasc)/mean
(Dypro, Dzasc)$$
The
two-sample t-test evaluated group differences, and Pearson correlation tested
for the relationship between ALPS index and clinical variables. Results
Our results showed a significant
increase in the right, left, and bilateral ALPS indexes respectively in middle-aged HIV
patients compared to healthy controls (Table 2, Figure 2). An increase in ALPS indexes along the right
periventricular white matter was significantly correlated (p = 0.0272, r
=0.450, Figure 3A) with attention and working memory in HIV patients at
stable cART regimen. In these
middle-aged HIV patients, a significant positive correlation was observed between
duration on cART and cognitive performance scores of abstract and executive
function (p = 0.0009, r =0.669, Figure 3B) and Learning and
recall (p = 0.0009, r =0.669, Figure 3C)Discussion
We
found that the ALPS index within the periventricular white matter was increased
in middle-aged HIV patients receiving cART. The ALPS index was also correlated
with some cognitive functions of these patients whose duration on cART was also
associated with cognitive functioning. These findings suggest that uncontrolled
viral proteins, inflammation, and other infectious activity of glial cells
might threaten glymphatic system activity in HIV patients; however, the long-term use of cART, in conjunction with brain compensatory mechanisms, may
synergistically enhance glymphatic system activity over time by reducing
inflammation8 and increasing activity
for the clearance of HIV-associated neurotoxins. This increase in glymphatic
system activity may also be a potential for improving or restoring homeostasis
associated with cognitive functioning of the brain. Further investigation is
needed as most of the available antiretroviral therapies are thought to be less
effective in reversing or improving HAND-related
neurological dysfunction9, and disrupt microglial
phagocytosis of β-amyloid in vitro studies10. Conclusion
The study suggests that ALPS index may be valuable in monitoring changes of glymphatic system activity in perivascular space. cART may be potential for enhancing glymphatic system activity over time, thereby improving or maintaining microenvironmental homeostasis for cognitive functions following HIV-neurotoxins. Further research is needed to understand the cellular mechanisms underlying activity changes in glymphatic system and the association with cognitive functions in middle-aged adults.Acknowledgements
We are grateful to all subjects who participated in this study. References
1. Gawron N, ChoiĆski M, SzymaĆska-Kotwica
B, et al. Effects of age, HIV, and HIV-associated clinical factors on
neuropsychological functioning and brain regional volume in HIV+ patients on
effective treatment. J Neurovirol
2019;25(1):9-21.
2. de Paula HHS,
Ferreira ACG, Caetano DG, et al. Reduction of inflammation and T cell
activation after 6 months of cART initiation during acute, but not in early
chronic HIV-1 infection. Retrovirology
2018;15(1):1-11.
3. Harrison IF,
Siow B, Akilo AB, et al. Non-invasive imaging of CSF-mediated brain clearance
pathways via assessment of perivascular fluid movement with diffusion tensor
MRI. Elife 2018;7:e34028.
4. Voldsbekk I,
Maximov II, Zak N, et al. Evidence for wakefulness-related changes to
extracellular space in human brain white matter from diffusion-weighted MRI. NeuroImage 2020:116682.
5. Yokota H,
Vijayasarathi A, Cekic M, et al. Diagnostic performance of glymphatic system
evaluation using diffusion tensor imaging in idiopathic normal pressure
hydrocephalus and mimickers. Current
Gerontology and Geriatrics Research 2019;2019
6. Mestre H,
Kostrikov S, Mehta RI, et al. Perivascular spaces, glymphatic dysfunction, and
small vessel disease. Clinical science
2017;131(17):2257-74.
7. Taoka T,
Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the
diffusion MR technique: diffusion tensor image analysis along the perivascular
space (DTI-ALPS) in Alzheimer’s disease cases. Japanese journal of radiology 2017;35(4):172-78.
8. Ellis R,
Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal
injury and repair. Nature Reviews
Neuroscience 2007;8(1):33-44.
9. Saylor D,
Dickens AM, Sacktor N, et al. HIV-associated neurocognitive
disorder—pathogenesis and prospects for treatment. Nat Rev Neurol 2016;12(4):234-48.
10.
Giunta B, Ehrhart J, Obregon DF, et al. Antiretroviral medications disrupt
microglial phagocytosis of β-amyloid and increase its production by neurons:
implications for HIV-associated neurocognitive disorders. Mol Brain 2011;4(1):1-6.